James S. Shannon's most recent trade in UL Solutions Inc - Ordinary Shares - Class A was a trade of 8 Deferred Restricted Stock Units done . Disclosure was reported to the exchange on March 12, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| UL Soln Inc (Class A) | James M. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2026 | 8 | 4,962 | - | - | Deferred Restricted Stock Units | |
| UL Soln Inc (Class A) | James M. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2026 | 4 | 2,805 | - | - | Deferred Restricted Stock Units | |
| Mannkind Corp | James S. Shannon | Director | Grant, award, or other acquisition of securities at price $ 3.27 per share. | 01 Mar 2026 | 12,000 | 64,635 (0%) | 0% | 3.3 | 39,240 | Common Stock, $0.01 Par Value |
| UL Soln Inc (Class A) | James M. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 176 | 1,619 | - | - | Deferred Stock Units | |
| UL Soln Inc (Class A) | James M. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 8 | 4,954 | - | - | Deferred Restricted Stock Units | |
| UL Soln Inc (Class A) | James M. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 4 | 2,801 | - | - | Deferred Restricted Stock Units | |
| UL Soln Inc (Class A) | James M. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2025 | 203 | 1,443 | - | - | Deferred Stock Units | |
| UL Soln Inc (Class A) | James M. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2025 | 10 | 4,946 | - | - | Deferred Restricted Stock Unit | |
| UL Soln Inc (Class A) | James M. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2025 | 5 | 2,797 | - | - | Deferred Restricted Stock Unit | |
| UL Soln Inc (Class A) | James M. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2025 | 189 | 1,240 | - | - | Deferred Stock Units | |
| UL Soln Inc (Class A) | James M. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2025 | 9 | 4,936 | - | - | Deferred Restricted Stock Unit | |
| UL Soln Inc (Class A) | James M. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2025 | 5 | 2,792 | - | - | Deferred Restricted Stock Unit | |
| UL Soln Inc (Class A) | James M. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2025 | 2,787 | 2,787 | - | - | Deferred Restricted Stock Unit | |
| Mannkind Corp | James S. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 52,854 | 52,854 | - | - | Restricted Stock Unit | |
| UL Soln Inc (Class A) | James M. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2025 | 235 | 1,051 | - | - | Deferred Stock Units | |
| UL Soln Inc (Class A) | James M. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 12 | 49 | - | - | Dividend Equivalent Rights | |
| UL Soln Inc (Class A) | James M. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 261 | 816 | - | - | Deferred Stock Units | |
| UL Soln Inc (Class A) | James M. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 11 | 37 | - | - | Dividend Equivalent Rights | |
| UL Soln Inc (Class A) | James M. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2024 | 257 | 555 | - | - | Deferred Stock Units | |
| UL Soln Inc (Class A) | James M. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2024 | 12 | 26 | - | - | Dividend Equivalent Rights | |
| UL Soln Inc (Class A) | James M. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2024 | 298 | 298 | - | - | Deferred Stock Units | |
| UL Soln Inc (Class A) | James M. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 14 | 14 | - | - | Dividend Equivalent Rights | |
| UL Soln Inc (Class A) | James M. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 4,878 | 4,878 | - | - | Restricted Stock Unit | |
| Mannkind Corp | James S. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 35,047 | 35,047 | - | - | Restricted Stock Unit | |
| UL Soln Inc (Class A) | James M. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 4,878 | 4,878 | - | - | Deferred Restricted Stock Unit | |
| UL Soln Inc (Class A) | James M. Shannon | Director | Purchase of securities on an exchange or from another person at price $ 28.00 per share. | 16 Apr 2024 | 7,142 | 7,142 | - | 28 | 199,976 | Class A Common Stock |
| UL Soln Inc (Class A) | James M. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2024 | 4,881 | 4,881 | - | - | Restricted Stock Unit | |
| Mannkind Corp | James S. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 47,393 | 47,393 | - | - | Restricted Stock Unit | |
| Horizon Therapeutics Plc | James S. Shannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 3,913 | 23,185 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | James S. Shannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 3,913 | 0 | - | - | Restricted Stock Units | |
| Horizon Therapeutics Plc | James S. Shannon | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 111.16 per share. | 28 Apr 2023 | 1,879 | 21,306 (0%) | 0% | 111.2 | 208,870 | Ordinary Shares |
| Mannkind Corp | James S. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2022 | 45,045 | 45,045 | - | - | Restricted Stock Unit | |
| Horizon Therapeutics Plc | James S. Shannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2022 | 4,223 | 0 | - | - | Restricted Stock Units | |
| Horizon Therapeutics Plc | James S. Shannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2022 | 4,223 | 44,568 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | James S. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 3,913 | 3,913 | - | - | Restricted Stock Units | |
| Horizon Therapeutics Plc | James S. Shannon | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 98.56 per share. | 28 Apr 2022 | 1,658 | 42,910 (0%) | 0% | 98.6 | 163,412 | Ordinary Shares |
| Mannkind Corp | James S. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 33,860 | 33,860 | - | - | Restricted Stock Unit | |
| Mannkind Corp | James S. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 11,338 | 11,338 | - | - | Restricted Stock Unit | |
| Horizon Therapeutics Plc | James S. Shannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2021 | 11,098 | 0 | - | - | Restricted Stock Units | |
| Horizon Therapeutics Plc | James S. Shannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2021 | 11,098 | 44,702 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | James S. Shannon | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 94.62 per share. | 29 Apr 2021 | 4,357 | 40,345 (0%) | 0% | 94.6 | 412,259 | Ordinary Shares |
| Horizon Therapeutics Plc | James S. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2021 | 4,223 | 4,223 | - | - | Restricted Stock Units |